Publication dates

Influenza Vaccine Industry, December 2014 Market Reports from Top Publishers

You might be interested in: Influenza, Vaccine, Drug Delivery, more »


 
1-10 of 82 reports for Influenza Vaccine

Vaccibody AS - Product Pipeline Review - 2014

Vaccibody AS - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

... Mechanism of action 13r&d progress 13influenza vaccine 14product description 14mechanism of action 14r&d progress 14tuberculosis vaccine 15product description 15mechanism of action 15 ...

Hualan Biological Engineering, Inc. (Symbol:002007) SWOT Analysis, Strategy, Revenues and Profits

Hualan Biological Engineering, Inc. (Symbol:002007) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... And surgical lyophilized fibrin sealant. Hualan biological offers vaccines, such as inactivated influenza vaccine, recombinant hepatitis b vaccine, meningococcal polysaccharide vaccine group acyw135 ...

FFF Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

FFF Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Deadlines, protect patientsoct 13, 2014: nation's largest distributor of influenza vaccines prepared to respond to vaccine delaysjul 14, 2014: fff enterprises welcomes brad cooper as chief financial ...

Glide Pharmaceutical Technologies Limited SWOT Analysis, Strategy, Revenues and Profits

Glide Pharmaceutical Technologies Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... The company offers pre-clinical development programs such as glide octreotide, glide parathyroid hormone, anthrax vaccine and glide influenza vaccine. It uses glide sdi, a patented drug delivery system ...

iBio, Inc. (IBIO) - Financial and Strategic SWOT Analysis Review

iBio, Inc. (IBIO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Applications. It offers products such as vaccines, and biotherapeutics. Ibio offers vaccines such as influenza vaccines, malaria, hookworm, yellow fever, human papilloma virus, and bacterial pathogens ...

Medicago Inc. (Symbol:MDG) SWOT Analysis, Strategy, Revenues and Profits

Medicago Inc. (Symbol:MDG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Partners, u.S. Department of defense (darpa), path grant, infectious disease research institute (idri), and u.S. Army research for commercial development of influenza vaccines. Medicago is headquartered ...

Adimmune Corporation (4142) - Financial and Strategic SWOT Analysis Review

Adimmune Corporation (4142) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Such as vaccines, diagnostics, and biological products. The company's vaccine products include japan encephalitis vaccine, tetanus toxoid adsorbed vaccine, influenza vaccine, and ah1n1 vaccine. It provides services ...

Xenetic Biosciences plc (XEN) - Financial and Strategic SWOT Analysis Review

Xenetic Biosciences plc (XEN) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Xen for vaccine delivery and oncohist. Its polyxen products include erepoxen, sulixen, pulmoxen and psa-rfviii cand. Xenetic also provides imuxen products such as myeloxen, influenza vaccine cand and hiv ...

BiondVax Pharmaceuticals Ltd. (BNDX) - Financial and Strategic SWOT Analysis Review

BiondVax Pharmaceuticals Ltd. (BNDX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... And manufactures universal flu (influenza) vaccine to provide multi-strain, multi-season and long-term protection against various flu viruses. It has completed two phase i/ii clinical trials for the multimeric-001 ...

UMN Pharma Inc. (4584) - Financial and Strategic SWOT Analysis Review

UMN Pharma Inc. (4584) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... vaccines. The company offers umn-2003 product, a norovirus vlp + rotavirus vp6 non-live injectable trivalent vaccine, for the prevention of two major causative agents of acute gastroenteritis in one ...

About 900 reports for Influenza Vaccine

Download Unlimited Documents from Trusted Public Sources

Global Vaccine Industry

  • April 2013
    70 pages
  • Vaccine  

    Influenza  

  • Europe  

    World  

View report >

1 Companies for Influenza Vaccine

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.